News and Blog

Sun, Sea and Science at the Elixir SME Forum, Barcelona

Elixir is truly ramping up engagement with SMEs across Europe this year, with not one, not two, but four SME forums in 2017. I sadly missed the first one in Helsinki in February, but I was not going to miss the second one in Barcelona on June 6th and 7th! I was kindly invited to join a panel discussion on "How can open data accelerate innovation?". And when one can combine business and leisure, there was no excuse. Indeed I managed to catch up with friends and family and enjoy a taste of early summer in this fantastic Olympic city near the sea.
 
During the forum, Alfonso Valencia shared how the INB (Instituto Nacional de Bioinformática) is scaling up its involvement in the coordination of Elixir-Spain. The Elixir project seems to provide a very good incentive to get the Spanish bioinformatics resources reorganised with some movement of people and capabilities, for maximum impact, which is very good thing. As an example, Alfonso Valencia, one of the INB directors and a veteran of the Spanish bioinformatics community iscurrently moving his team from Madrid to

the Barcelona Supercomputing Center. Their supercomputer has the most unusual home at the chapel Torre Girona, a 19th-Century church building. What an inspired place to offer a "cold" machine a soul! I did not have time for a visit, but next time, I'll make sure to ask for one to Josep Lluis Gelpi, INB Team Leader, who I met during the SME forum.
 
In the panel discussion, I contributed to the never ending controversial debate about the blurred boundaries between academia and industry remits, when sometimes they step on each other toes and other times work in synergy, as it should be. I pushed the debate about health data wondering why some of us consider it different and more revealing about ourselves than any data we happily share on social media that is as intimate and revealing, if not more. My argument was if I'm the owner of my social data and happy to provide access to it willingly to corporations such as LinkedIn, Facebook, Google, Twitter, why can't I be given the same freedom with my health data through similar technology platforms? A very good and "heated" discussion ensued.
IMG_2446.jpg
The SME forum took place at the PRBB, (Barcelona Biomedical Research Park) home of 7 great and complementary organisations. Close to my heart and area of expertise is the CRG that has been at the forefront of many cutting edge genomics research since 2000 in the ramp up of the human genome project, and the newly established EMBL outstation.
 
Look at this building (right), and its location at the centre of this fantastic city and just 200 yards from the beach , the perfect environment to attract incredible talent from around the world, perfect for serendipity to spread free and foster innovation!
 
After a well deserved summer break, I'm looking forward to the next Elixir SME forums in October (Brussels) and November (Paris)!
 
 
IMG_2447-2.jpg
 

Abel Ureta-Vidal Eagle at an event Life science life science events elixir

Abel Ureta-Vidal

About Abel Ureta-Vidal

With more than 12 years of bioinformatics experience and a scientific background in molecular biology and immune-virology (PhD from the Pasteur Institute, France), Abel first mastered bioinformatics tools and code in the early 90s whilst working on viral phylogenetic studies. After his PhD, he joined the effort at Genoscope (Evry, France), in ramping up the human genome project, putting in place the automatic gene annotation system for human chromosome 14. In 2001, Abel moved to the European Bioinformatics Institute (Cambridge, UK) where he led the Ensembl comparative genomics team until 2007. He founded Eagle shortly before graduating from the Cambridge Judge Business School MBA program in 2008.